
Jeffrey P Callen MD FACP, FAAD
Professor of Medicine (Dermatology), University of Louisville, Lafayette G. Owen Chair, Chief, Division of Dermatology
Join to View Full Profile
3810 Springhurst Blvd.Suite 200Louisville, KY 40241
Phone+1 502-583-1749
Fax+1 502-329-7599
Dr. Callen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Callen is a dermatologist in Louisville, KY and is affiliated with University of Louisville. He received his medical degree from University of Michigan and has been in practice 47 years. He is experienced in dermatomyositis, lupus erythematosus, vasculitis, sarcoidosis, severe cutaneous drug reactions
Education & Training
University of MichiganResidency, Dermatology, 1977
University of MichiganResidency, Internal Medicine, 1972 - 1975
University of MichiganInternship, Internal Medicine, 1972 - 1973
University of Michigan Medical SchoolClass of 1972
University of Wisconsin (Madison)BS, 1965 - 1969
Certifications & Licensure
CA State Medical License Active through 2027
KY State Medical License 1977 - 2027
IN State Medical License 1992 - 2019
FL State Medical License 2015 - 2017
OH State Medical License 1991 - 2009
IL State Medical License 1996 - 2002
MI State Medical License 1973 - 2001
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Lifetime Career Education Awardee Dermatology Foundation, 2018
- America's Top Doctors Castle Connolly, 2002-2017
- Master Dermatologist 2017 American Academy of Dermatology, 2017
Publications & Presentations
PubMed
- Upadacitinib for recalcitrant extraintestinal Crohn disease.Avery H Seward, Jeffrey P Callen
JAAD Case Reports. 2026-04-01 - Characterizing superficial epidermolytic ichthyosis in a patient with KRT2 mutation responsive to ustekinumab.Mallory Zaino, Jordan Jones, Ronghua Hu, Keith Choate, Jeffrey P Callen
JAAD Case Reports. 2026-03-01 - Generalized bullous fixed drug eruption related to intravenous contrast.Eliana Figueredo Zamora, Jeffrey P Callen
Dermatology Online Journal. 2025-09-08
Journal Articles
- Necrotizing Neutrophilic Dermatitis, an Often-Misdiagnosed Entity with Potentially Severe ConsequencesJeffrey Callen, MD, JAMA
- Cutaneous Lupus Erythematosus: Reflecting on Practice-Changing Observations over the Past 50 YearsJeffrey Callen, MD, ScienceDirect
- Cutaneous Lupus Erythematosus: Reflecting on Practice-Changing Observations over the Past 50 YearsJeffrey Callen, MD, Clinics in Dermatology
Books/Book Chapters
Abstracts/Posters
- A case of postoperative pyoderma gangrenosum successfully treated with infliximab.Thompson CB, Kulp-Shorten CL, Callen JP, J Am Acad Dermatol, 1/1/2016
- Doxycycline phototoxic reaction mimicking SJS/TEN.Skaggs R, Owen CE, Callen JP, J Am Acad Dermatol, 1/1/2016
- The Use of Cyclosporine for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The University of Louisville ExperienceMcKenzie EG, Owen CE, Callen JP, J Am Acad Dermatol, 1/1/2016
Lectures
- Journal WatchingAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- Essentials of Medical Dermatology - Prior Approval Necessary to AttendAmerican Academy of Dermatology, Itasca, Illinois - 9/21/2012
- Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual MeetingFlorida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012
Other
- Recognition and Management of Severe Cutaneous Drug Reactions.Dialogues in Dermatology
1/1/2007 - Adverse Drug reactions that mimic systemic diseases.Dialogues in Dermatology
1/1/2002 - Review of Textbook of Neonatal Dermatology. Eichenfield L, Frieden I, Esterly N editors.Callen JP, Doody’s Review Service (on-line).
http://www.doody.com
1/1/2001
Press Mentions
Validity of Commercial Serologic Tests for Dermatomyositis Still QuestionableNovember 24th, 2021
Adverse Cutaneous Reactions to Hydroxychloroquine Are More Common in Patients with Dermatomyositis Than in Patients with Cutaneous Lupus ErythematosusOctober 16th, 2019
Good to Begin Well, Better to End WellJuly 20th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









